机构:[1]School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China [2]Department of Cardiology, The Sixth Medical Center of People's Liberation Army General Hospital, Beijing, China [3]Department of Vascular Medicine, Peking University Shougang Hospital, Beijing 100144, China [4]Guang'anmen Hospital of Chinese Academy of Traditional Chinese Medicine, Beijing, China
This study is supported by the NSFC (82270279 and 82200296),
Natural Science Foundation of ShenZhen (JCYJ20210324103808023),
and Educational Committee of Guangdong for Specific Program of Key
Scientific Research (2021ZDZX2016).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|1 区内分泌学与代谢
最新[2025]版:
大类|1 区医学
小类|1 区内分泌学与代谢
第一作者:
第一作者机构:[1]School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China [2]Department of Cardiology, The Sixth Medical Center of People's Liberation Army General Hospital, Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhou Hao,Dai Zhe,Li Jialei,et al.TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury[J].Metabolism: clinical and experimental.2023,140:155383.doi:10.1016/j.metabol.2022.155383.
APA:
Zhou Hao,Dai Zhe,Li Jialei,Wang Jin,Zhu Hang...&Wang Yijin.(2023).TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury.Metabolism: clinical and experimental,140,
MLA:
Zhou Hao,et al."TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury".Metabolism: clinical and experimental 140.(2023):155383